oral semaglutide efficacy found to lower risk of heart failure events in people with type 2 diabetes Levels of circulating semaglutide determine

Conclusion Why Choose Enhanced Aesthetics & Wellness for Semaglutide Treatment

Setmelanotide is FDA-approved but restricted to rare genetic obesity syndromes and priced accordingly

Did you know that hiccups can occur for a myriad of reasons, ranging from eating too quickly to sudden changes in temperature

Key TakeawaysGLP-1 drugs might lower the risk of dangerous blood clots and death among people with autoimmune diseasesPeople taking GLP-1 drugs were 44% less likely to dieThey also had a lower risk of blood clots in their lungs or causing a stroke.WEDNESDAY, June 17, 2026 (HealthDay News) People with an autoimmune disease and obesity might lower their risk of dangerous blood clots and death by taking Ozempic or Zepbound, a new study says.Autoimmune diseases like celiac disease, vitiligo, psoriasis or rheumatoid arthritis increase the risk of severe heath emergencies because they cause inflammation and malfunctioning immune responses, researchers said.But GLP-1 medications might be able to counter that risk, researchers reported recently in the Journal of the American Heart Association.Overall, peoples risk of death was cut by nearly half if they were taking a GLP-1 drug, the study found.In this real-world analysis, we found a consistent signal toward fewer serious complications including blood clots and lower mortality among patients treated with GLP-1 receptor agonists, senior researcher Dr